These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 10665936)
1. A mouse model of renal tubular injury of tyrosinemia type 1: development of de Toni Fanconi syndrome and apoptosis of renal tubular cells in Fah/Hpd double mutant mice. Sun MS; Hattori S; Kubo S; Awata H; Matsuda I; Endo F J Am Soc Nephrol; 2000 Feb; 11(2):291-300. PubMed ID: 10665936 [TBL] [Abstract][Full Text] [Related]
2. Tyrosinaemia type I and apoptosis of hepatocytes and renal tubular cells. Endo F; Sun MS J Inherit Metab Dis; 2002 May; 25(3):227-34. PubMed ID: 12137232 [TBL] [Abstract][Full Text] [Related]
3. Complete rescue of lethal albino c14CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway. Endo F; Kubo S; Awata H; Kiwaki K; Katoh H; Kanegae Y; Saito I; Miyazaki J; Yamamoto T; Jakobs C; Hattori S; Matsuda I J Biol Chem; 1997 Sep; 272(39):24426-32. PubMed ID: 9305902 [TBL] [Abstract][Full Text] [Related]
7. Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1. Aponte JL; Sega GA; Hauser LJ; Dhar MS; Withrow CM; Carpenter DA; Rinchik EM; Culiat CT; Johnson DK Proc Natl Acad Sci U S A; 2001 Jan; 98(2):641-5. PubMed ID: 11209059 [TBL] [Abstract][Full Text] [Related]
8. Kidneys of mice with hereditary tyrosinemia type I are extremely sensitive to cytotoxicity. Jacobs SM; van Beurden DH; Klomp LW; Berger R; van den Berg IE Pediatr Res; 2006 Mar; 59(3):365-70. PubMed ID: 16492973 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte injury in tyrosinemia type 1 is induced by fumarylacetoacetate and is inhibited by caspase inhibitors. Kubo S; Sun M; Miyahara M; Umeyama K; Urakami K; Yamamoto T; Jakobs C; Matsuda I; Endo F Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9552-7. PubMed ID: 9689118 [TBL] [Abstract][Full Text] [Related]
10. Tissue-specific FAH deficiency alters sleep-wake patterns and results in chronic tyrosinemia in mice. Yang S; Siepka SM; Cox KH; Kumar V; de Groot M; Chelliah Y; Chen J; Tu B; Takahashi JS Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22229-22236. PubMed ID: 31611405 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological rescue of the 14CoS/14CoS mouse: hepatocyte apoptosis is likely caused by endogenous oxidative stress. Dieter MZ; Freshwater SL; Miller ML; Shertzer HG; Dalton TP; Nebert DW Free Radic Biol Med; 2003 Aug; 35(4):351-67. PubMed ID: 12899938 [TBL] [Abstract][Full Text] [Related]
12. Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1. Li L; Zhang Q; Yang H; Zou Q; Lai C; Jiang F; Zhao P; Luo Z; Yang J; Chen Q; Wang Y; Newsome PN; Frampton J; Maxwell PH; Li W; Chen S; Wang D; Siu TS; Tam S; Tse HF; Qin B; Bao X; Esteban MA; Lai L J Biol Chem; 2017 Mar; 292(11):4755-4763. PubMed ID: 28053091 [TBL] [Abstract][Full Text] [Related]
13. Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1. Ates I; Stuart C; Rathbone T; Barzi M; He G; Major AM; Shankar V; Lyman RA; Angner SS; Mackay TFC; Srinivasan S; Farris AB; Bissig KD; Cottle RN Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38668730 [TBL] [Abstract][Full Text] [Related]
14. Efficient liver repopulation of transplanted hepatocyte prevents cirrhosis in a rat model of hereditary tyrosinemia type I. Zhang L; Shao Y; Li L; Tian F; Cen J; Chen X; Hu D; Zhou Y; Xie W; Zheng Y; Ji Y; Liu M; Li D; Hui L Sci Rep; 2016 Aug; 6():31460. PubMed ID: 27510266 [TBL] [Abstract][Full Text] [Related]
15. Gene expression profiles of homogentisate-treated Fah-/- Hpd-/-mice using DNA microarrays. Tanaka Y; Nakamura K; Matsumoto S; Kimoto Y; Tanoue A; Tsujimoto G; Endo F Mol Genet Metab; 2006 Nov; 89(3):203-9. PubMed ID: 16899383 [TBL] [Abstract][Full Text] [Related]
16. An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1. Gu P; Xie L; Chen T; Yang Q; Zhang X; Liu R; Guo J; Wei R; Li D; Jiang Y; Chen Y; Gong W; Chen P J Hepatol; 2024 Mar; 80(3):454-466. PubMed ID: 37952766 [TBL] [Abstract][Full Text] [Related]
17. Biochemical and Clinical Aspects of Hereditary Tyrosinemia Type 1. Morrow G; Tanguay RM Adv Exp Med Biol; 2017; 959():9-21. PubMed ID: 28755181 [TBL] [Abstract][Full Text] [Related]
18. Molecular Aspects of the FAH Mutations Involved in HT1 Disease. Morrow G; Angileri F; Tanguay RM Adv Exp Med Biol; 2017; 959():25-48. PubMed ID: 28755182 [TBL] [Abstract][Full Text] [Related]
19. Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah-/- knockout mice model. Orejuela D; Jorquera R; Bergeron A; Finegold MJ; Tanguay RM J Hepatol; 2008 Feb; 48(2):308-17. PubMed ID: 18093685 [TBL] [Abstract][Full Text] [Related]
20. Rescue of mice homozygous for lethal albino deletions: implications for an animal model for the human liver disease tyrosinemia type 1. Kelsey G; Ruppert S; Beermann F; Grund C; Tanguay RM; Schütz G Genes Dev; 1993 Dec; 7(12A):2285-97. PubMed ID: 8253377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]